OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome	348
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	294
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	269
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	217
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	167
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	160
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	155
DNA Damage and Repair in Thyroid Physiology and Disease	149
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	140
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	122
The Molecular Biology of Midgut Neuroendocrine Neoplasms	117
Effects of Maternal Vitamin D Supplementation on Childhood Health	114
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity	108
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	107
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	92
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	89
Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion	88
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	87
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	87
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	85
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management	82
The Biology and Clinical Implications of PCSK7	80
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	74
Estrogen Receptor Signaling in the Immune System	73
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	66

Contemporary Biological Insights and Clinical Management of Craniopharyngioma	64
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	63
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	63
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”	63
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	62
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	61
Steroid receptor coactivators: from basic research to translational opportunities	59
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	56
Glycated CD59, a Novel Biomarker for Gestational Diabetes	56
Imaging of Pheochromocytomas and Paragangliomas	55
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	55
The Cortisol Awakening Response: Regulation and Functional Significance	54
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases	53
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	52
Adiponectin and Adiponectin Receptors in Atherosclerosis	51
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	49
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	49
Epigenetics and disease progression in neuroendocrine neoplasms	48
Brown Adipose Tissue—A Translational Perspective	48
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities	47
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	47
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	46
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	46
Endocrine Controls of Skin Aging	46
Medullary Thyroid Cancer: Updates and Challenges	44
Protective Factors and the Pathogenesis of Complications in Diabetes	44
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	42
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency	42
Retraction and Replacement of: “Effects of Maternal Vitamin D Supplementation on Childhood Health”	42
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	38
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	38
Teprotumumab for the Treatment of Thyroid Eye Disease	38
Carbohydrate Ingestion on Exercise Metabolism and Physical Performance	37
Acromegaly and Cardiovascular Disease: Mechanisms, Clinical Impact, and Evolving Management	36
Update on Adipose Tissue and Cancer	33
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	33
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	28
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	28
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	27
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	26
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens	26
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies	25
Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis	25
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	25
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	24
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	24
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	24
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications	23
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	23
Endocrine Dysfunction in Primary Mitochondrial Diseases	22

Management of postmenopausal osteoporosis	21
Correction to: “Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease”	21